Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate for pediatric and adolescent general anesthesia surgery patients
CTR20252370Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of remimazolam in procedural sedation and analgesia (PSA), sponsored by Hengrui Therapeutics. Started Jul 2025; status: completed.
02
Drugs
remimazolam
03
Conditions
procedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on CTR20252370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252370.